project id: TCGA-MESO; case submitter id: TCGA-MQ-A4LV; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 9.0; age at index: 63; days to birth: -23110; days to death: 107; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1939; year of death: 2002; age at diagnosis: 23110; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2002; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 160.0; sample id: fe47ad4b-5f1e-4ee9-bce2-a1800f67d9a2; sample submitter id: TCGA-MQ-A4LV-01A; portion id: 1ac7027c-b7ff-40ce-ad4e-6e0a32df702b; portion submitter id: TCGA-MQ-A4LV-01A-11; slide id: b78b9301-84ca-49a2-a1f5-64128d5057db; slide submitter id: TCGA-MQ-A4LV-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 7.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 23.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;